Glucotrack and Lōkahi Therapeutics Complete Business Merger
The merger establishes a public platform for healthcare asset advancement.
Glucotrack, Inc. has finalized its strategic merger with Lōkahi Therapeutics, creating a publicly traded platform focused on the identification and advancement of healthcare assets. This merger positions Lōkahi as the controlling entity of the newly formed organization, allowing it to use Glucotrack's established public market access for future growth.
The newly combined company will use Lōkahi Therapeutics’ dual-engine model, which includes late-stage clinical development as well as an ai²-driven platform for sourcing and advancing therapeutic assets. This integration aims to create a scalable framework for value creation within the healthcare sector.
Lōkahi’s securityholders will receive a mix of common and convertible preferred stock from Glucotrack, with the latter expected to convert into common equity following necessary stockholder approvals. This will result in Lōkahi securityholders owning around 90% of the merged entity on a fully diluted basis, subject to customary adjustments.
A private placement financing is also planned to bolster the combined company's capital position and support immediate operational needs. A portion of the funds will be allocated to Glucotrack's existing continuous blood glucose monitoring technology, which will be maintained as a wholly owned subsidiary.
Erik Emerson has been appointed as the CEO of the merged company, with Paul Goode serving as the Chief Technical Officer and CEO of the glucose monitoring subsidiary. Emerson emphasized the merger's goal of creating a capital-efficient platform for systematically acquiring and advancing healthcare innovations.
This merger reflects a growing trend in the healthcare sector where companies are increasingly seeking to combine resources to enhance operational efficiency and market reach. The integration of Lōkahi’s advanced asset sourcing capabilities with Glucotrack’s technology infrastructure is expected to open new avenues for growth and development.
The announcement was made via GlobeNewswire, highlighting the strategic significance of this merger in the evolving healthcare landscape.
This is an independent summary of a press release originally distributed via GlobeNewswire. GAX Online was not paid for this coverage.
Have news to announce?
Get your launch, funding round, or partnership covered on GAX Online, in front of tech buyers and the AI answer engines that cite us.
Submit your press release →